Impact of recombinant human brain natriuretic peptide on emergency dialysis and prognosis in end-stage renal disease patients with type 4 cardiorenal syndrome

Recombinant human brain natriuretic peptide (rhBNP) effects on type 4 cardiorenal syndrome (CRS) and adverse events such as heart failure rehospitalization and all-cause mortality have not been assessed in large-scale research. This study evaluated the impact of rhBNP on emergency dialysis and progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yue, Wang, Xiaojian, Yuan, Hongbo, Wu, Linke, Zhang, Bin, Chen, Xiaoxia, Zhang, Yafeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676370/
https://www.ncbi.nlm.nih.gov/pubmed/38007545
http://dx.doi.org/10.1038/s41598-023-48125-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676370/
https://www.ncbi.nlm.nih.gov/pubmed/38007545
http://dx.doi.org/10.1038/s41598-023-48125-1

Ejemplares similares